Business Description
Level Bio AB
NAICS : 334517
ISIN : SE0000885501
Compare
Compare
Traded in other countries / regions
LEVBIO.Sweden4MB.Germany IPO Date
2021-05-05Description
Level Bio AB formerly AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.09 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.86 | |||||
| Beneish M-Score | -5.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.5 | |||||
| 3-Year Book Growth Rate | 42.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.21 | |||||
| 9-Day RSI | 56.3 | |||||
| 14-Day RSI | 53.82 | |||||
| 6-1 Month Momentum % | -55.56 | |||||
| 12-1 Month Momentum % | -34.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.46 | |||||
| Quick Ratio | 0.94 | |||||
| Cash Ratio | 0.48 | |||||
| Days Inventory | 150.77 | |||||
| Days Sales Outstanding | 60.81 | |||||
| Days Payable | 50.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 | |||||
| Shareholder Yield % | -2.5 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.76 | |||||
| Operating Margin % | -46.67 | |||||
| Net Margin % | -49.04 | |||||
| FCF Margin % | -19.73 | |||||
| ROE % | -82.01 | |||||
| ROA % | -53.88 | |||||
| ROIC % | -66.83 | |||||
| ROC (Joel Greenblatt) % | -327.16 | |||||
| ROCE % | -79.36 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.88 | |||||
| PB Ratio | 2.54 | |||||
| EV-to-EBIT | -1.53 | |||||
| EV-to-EBITDA | -1.89 | |||||
| EV-to-Revenue | 0.77 | |||||
| EV-to-FCF | -3.9 | |||||
| Price-to-Median-PS-Value | 0.29 | |||||
| Earnings Yield (Greenblatt) % | -65.36 | |||||
| FCF Yield % | -22.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Level Bio AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.017 | ||
| EPS (TTM) (€) | -0.016 | ||
| Beta | 0.57 | ||
| Volatility % | 61.21 | ||
| 14-Day RSI | 53.82 | ||
| 14-Day ATR (€) | 0.004078 | ||
| 20-Day SMA (€) | 0.0167 | ||
| 12-1 Month Momentum % | -34.96 | ||
| 52-Week Range (€) | 0.0045 - 0.0582 | ||
| Shares Outstanding (Mil) | 63.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Level Bio AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Level Bio AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Level Bio AB Frequently Asked Questions
What is Level Bio AB(FRA:4MB)'s stock price today?
The current price of FRA:4MB is €0.02. The 52 week high of FRA:4MB is €0.06 and 52 week low is €0.00.
When is next earnings date of Level Bio AB(FRA:4MB)?
The next earnings date of Level Bio AB(FRA:4MB) is 2024-08-22.
Does Level Bio AB(FRA:4MB) pay dividends? If so, how much?
Level Bio AB(FRA:4MB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers